SPER Market Research - Top Market Research Company in India

Loading

Loading.

Loading..

Loading...

SPER Market Research


SPER Market Research

SPER Market Research is a global market research, market intelligence, competitive intelligence and consulting organization.

SPER Market Research

SPER Market Research is a global market research, market intelligence, competitive intelligence and consulting organization.

SPER Market Research

SPER Market Research is a leading, full-service global market research/business intelligence and consulting company offering quantitative data collection, qualitative fieldwork, strategic research, desk research and market intelligence solutions.

Established in 2015, SPER Market Research is a global market research, market intelligence, competitive intelligence and consulting organization with substantial presence in healthcare and chemical domain which includes pharmaceuticals, medical devices & equipment, specialty chemicals, food & beverages, nutraceuticals & cosmeceuticals etc.
We integrate deep healthcare and pharmaceutical expertise with proven research methodologies to analyze high-quality, country-specific data from a combination of primary and secondary market research techniques to deliver precise, relevant data to understand the market dynamics. In the last four years, we have successfully delivered more than 300+ projects for over 40+ clients.

SPER Study Image

What We Do

We integrate deep healthcare and pharmaceutical expertise with proven research methodologies to analyze high-quality, country-specific data from a combination of primary and secondary market research techniques to deliver precise, relevant data to understand the market dynamics.

Our Services

Qualitative

Qualitative

Focus Group Discussions In-depth Interviews Face-to-Face Interviews Recruiting

Quantitative

Quantitative

CAPI CATI PAPI Telephone Surveys Online Surveys

Consulting

Consulting

Business-to-Business Research Consumer Research International Research Marketing Research

Secondary Research

Secondary Research

Customized Research Market Sizing & Forecasting Competitive Landscape Analysis Indication-Wise Pipeline Analysis

Analytical

Analytical

Data Driven Consultancy Statistical Analysis

Solutions

Solutions

Brand Research Business-to-Business Consumer Research Customer Satisfaction Studies

Join SPER Panel

Our Salient Features

Countries

Countries

Multi-industry research across many countries.

Moderators

Moderators

100+ moderators with rich professional background.

Time-line

Time-line

Strictly adhere with the time-line.

Interviews

Interviews

90,000 telephonic interviews/year.

Quality Work

Quality Work

95% repeat business speaks for our quality work.

Delivery

Delivery

Quality delivery with high turnaround time.

Orthodontics Market

Orthodontics Market is projected to be worth around USD 7,216.0 Million by 2027

The global orthodontics market is expected to grow at a CAGR of 10.9% from 2019 to reach USD 7,216.0 million by 2027. The growing number of dentists, increasing prevalence of malocclusion, and growing awareness about advanced orthodontic treatments are the key factors driving the growth of this market. In addition, adoption of advanced imaging modalities and treatment planning software are further expected to increase the number and quality of orthodontic treatments which in turn will drive the market growth. On the other hand, the high cost of advanced orthodontic treatments and limited reimbursement is expected to hinder the growth of this market.

Browse report overview on "Orthodontics Market - Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecast to 2027" at: https://www.sperresearch.com/report-store/Orthodontics-Market.aspx

The dental industry is witnessing a big boost across the world. The orthodontic equipment are increasingly adopted for the treatment of misaligned teeth. Orthodontic treatment is important for oral health as well as improves the overall appearance of the person. Well-aligned and straight teeth are easy to maintain. Owing to the several clinical and aesthetic benefits offered by the orthodontic treatment, the demand for orthodontic products is growing rapidly. 

In addition, growing awareness about dental malocclusion and the presence of advanced tools that aid in early detection have increased the patient population for orthodontic treatment. Moreover, gradual shift towards preventative oral care, growing concern for hygiene of the equipment, and favourable health reimbursement for treatment of dental malocclusion are anticipated to propel growth of the orthodontic market during the forecast period.

Currently, the orthodontic market is witnessing several new technological advancements. With the advent of scanning and imaging tools, orthodontists can plan the treatment and design custom made braces for better results. Nowadays, several players are focusing to launch new digital software for the tailor-made smile which, in turn, is encouraging people for orthodontic treatment.  

The emergence of dental 3D scanners and dental imaging has reduced the need for handwritten descriptions and aided in effective treatment planning with virtual images of the patient's jaw, teeth, and mouth. The introduction of technologically advanced diagnostic tools by key manufacturers for the clinical diagnosis of oral health as well as the detection of misaligned teeth has enhanced the treatment quality of orthodontics. Furthermore, the integration of CAD/CAM and 3D technologies, IoT software, and AI-based technologies with orthodontic techniques to accurately treat the misaligned teeth of a patient is driving the market growth.  

The global orthodontics market study provides market data -by product (removable, fixed braces (brackets (metal, ceramics), archwire (beta titanium, stainless steel), anchorage appliances, ligature, retainers). On the basis of product, removable braces commanded the largest share of the global orthodontics market. Also, this segment is expected to grow at the highest CAGR during the forecast period. The largest share and high growth rate are mainly attributed to the growing adoption of invisible braces in developed countries and a growing number of orthodontic treatments in emerging countries. In addition, a decrease in prices of clear aligner has further expected to drive the adoption of removable braces, especially in emerging countries.

The global orthodontics market study provides market data - by patient (children and teen, adult). The study also evaluates industry competitors and analyzes the market at a regional and country level. On the basis of the patient, children and teen accounted for the largest share of the orthodontics market. The large share and high growth of this market is mainly attributed to the growing adoption of invisible braces among teens in developed countries, increasing adoption of orthodontic treatment, and growing number of orthodontists across the globe.

This research report analyzes major geographies and provides a comprehensive analysis of North America (US, Canada), Europe (Spain, France, Italy, Germany, UK, and RoE), Asia-Pacific (China, India, Japan, and RoAPAC), Latin America, and Middle East & Africa. North America accounted for the largest share of the orthodontics market in 2020. Growth of this market is mainly attributed to the growing adoption of invisible braces, increasing adoption of orthodontic treatment, and growing number of orthodontists along with increasing number of general dentists offering orthodontic treatment. The Asia-Pacific orthodontics market is expected to grow at a highest CAGR during the forecast period with the large patient pool seeking orthodontic treatment, increasing the number of dentist and dental clinics, and expanding the presence of key players in this region.

Don’t miss out on business opportunities in the global orthodontics market. Request customized report as per your need and gain crucial industry insights that will help your business grow at: https://www.sperresearch.com/report-store/Orthodontics-Market.aspx?cutom=1

The orthodontics market is consolidated with Align Technology, Ormco Corporation, 3M, and Institute Straumann AG, having the dominant position. Other players operating in the global orthodontics market are 
  • G&H Orthodontics (US)
  • Straumann AG (Switzerland)
  • Dentsply Sirona Inc (US)
  • Ultradent Products Inc. (US) 
  • Great Lakes Orthodontics Ltd. (US)
  • DB Orthodontics (UK)
  • Dental Morelli Ltda. (Brazil)
  • DENTAURUM GmbH & Co. (Germany)
  • TP Orthodontics, Inc. (US) among many others.

Read more..

Artificial Intelligence (AI) in Healthcare Market

AI in Healthcare Market is projected to be worth around USD 52.7 Billion by 2027. Adoption of advanced technologies by pharmaceutical companies and hospitals is driving the demand for artificial intelligence in healthcare market.

The AI in Healthcare market is expected to grow at a CAGR of 42.7% from 2020 to reach to USD 52.7 billion by 2027. The high growth of healthcare artificial intelligence market is mainly attributed to the rising venture capital investment for artificial intelligence in healthcare sector, growing demand for personalized therapy, positive impact due to COVID-19, rising demand to reduce healthcare costs, and rise in volume and complexities of healthcare datasets. Moreover, the growing potential of AI based tools in accelerating clinical trials and treatment of chronic illness offers high growth opportunities for the players operating in the healthcare artificial intelligence market. However, the reluctance in adopting AI technologies and data security concerns are expected to hamper the growth of the healthcare artificial intelligence market to a certain extent.

Browse report overview on "Artificial Intelligence in Healthcare Market - Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecast to 2027" at: https://www.sperresearch.com/report-store/AI-Healthcare-Market.aspx

Artificial intelligence helps medical professionals to retrieve information, interpret images, and plan therapy during medical procedures. It also eases the burden on healthcare workers. Government and private companies are focusing on incorporating artificial intelligence in research activities currently, to accelerate developments related to COVID-19 vaccines.

The market for artificial intelligence in healthcare has witnessed major increase in demand due to the coronavirus pandemic. Its usage minimizes the risk of transmission as it limits human interaction and shields frontline workers. Pharmaceutical companies are among the primary companies adopting AI for development of vaccines and to study different strains of the virus.

The growing trend of increasing use of precision medicines and increasing clinical trial processes is supporting demand for and deployment of artificial intelligence in the healthcare the sector. Increase in prevalence of chronic diseases and increasing geriatric population will contribute significantly to growth of the market. Players in the pharmaceutical market are increasingly adopting artificial intelligence to develop novel drugs and speed up overall processes. Artificial intelligence is used in research for cancer and disease management, which has been increasing in the recent past, and this is expected to drive growth of the artificial intelligence in the healthcare market over the forecast period.

The global healthcare artificial intelligence market (2018-2027) study provides market data for- by product & services (software, hardware, and services), technology (machine learning, natural language processing, context aware processing, and querying method), application (medical imaging and diagnosis, drug discovery, precision medicine, hospital workflow), end user (hospitals and diagnostic centers, pharmaceutical and biopharmaceutical companies), and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.

On the basis of product & services, the overall healthcare artificial intelligence market is broadly segmented into software, hardware, and services. The software segment accounted the largest share of the overall healthcare artificial intelligence market in 2020. The large share of this segment is mainly attributed to the factors such as its ability to reduce operational or administrative complexity, acceleration of data analysis with high accuracy, and rise in the software launch by the medical devices and healthcare IT companies. Further, due to the COVID-19 pandemic since November 2019, there is an expansion in the software solutions which helps the healthcare specialists to track the disease progression and recovery in COVID-19 patients, thereby helping in the crisis situation.

On the basis of technology, the overall healthcare AI market is segmented into Machine Learning, Natural Language Processing, Context Aware Processing, and Querying Method. The NLP segment accounted for the largest share of the overall healthcare artificial intelligence market in 2020. The factors such as ability to collect large amount of data and handle big data, offering of organized physician documentation, and efficient back-end coding to optimize billing procedure are the major factors responsible for the largest share of this segment.

Based on end user, the healthcare artificial intelligence market is broadly segmented into hospitals and diagnostic centers, pharmaceutical and biopharmaceutical companies, healthcare payers, patients, and others which include Accountable Care Organizations, clinical research organizations, and managed care organizations.  The hospitals and diagnostic centers segment commanded the largest share of the overall healthcare artificial intelligence market in 2020. However, the healthcare payers segment is expected to grow at the fastest CAGR during the forecast period, due to growth in opting of healthcare insurance; and increasing inclination of healthcare facilities to have organized billing and accounts, health claims, and healthcare IT operations in their premises.

This research report analyzes major geographies and provides comprehensive analysis for North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America dominated the global healthcare artificial intelligence market in 2020, followed by Europe and Asia Pacific. Well established IT infrastructure in healthcare, presence of innovative software vendors and venture capitalists, rising adoption of EHR, flourishing biopharmaceutical industry, rise in funding for new product development, and increasing number of startups for healthcare artificial intelligence in the region supported the largest share of the North America in the healthcare artificial intelligence market.

Globally the market is witnessing the massive start-up enrolment. These key players are collaborating with each other to ffer customizaed AI solutions. However, the prominent players of the market are focusing on the research and development, to cater the rising needs of the end users. Prominent market players operating in the healthcare AI market include IBM Watson Health, Modernizing Medicine, NVIDIA Corporation, Sophia Genetics among others. New product launch & approval and partnerships are the most commonly adopted business strategies to sustain market position.

Don’t miss out on business opportunities in the AI in healthcare market. Request customized report as per your need and gain crucial industry insights that will help your business grow at: https://www.sperresearch.com/report-store/AI-Healthcare-Market.aspx?cutom=1

The key players operating in the global healthcare artificial intelligence market are 
  • Microsoft Corporation (US)
  • Alphabet Inc. (US)
  • NVIDIA Corporation (US)
  • General Vision, Inc (US)
  • Intel Corporation (US)
  • IBM Corporation (US)
  • Welltok, Inc. (US)
  • General Electric Company (US)
  • Verint Systems Inc. (US)
  • iCarbonX (China), among others.

Read more..

Cleanroom Technology Market

Press Release – The Global Cleanroom Technology Market is expected to reach USD 7.6 billion by 2027

A report titled “Global Cleanroom Technology Market - Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2027” which is anticipated to reach USD 7.6 billion by 2027. According to the study, the market is anticipated to portray a CAGR of 8.0% between 2020 to 2027. 

Some of the key factors boosting the cleanroom technology market are technical advancements, strict regulatory requirements, and increased demand from pharmaceutical and biopharmaceutical companies to produce quality goods. The steady evolution of the industry has been fuelled by regulatory thrust and customer demands for higher quality goods in these settings. 

The growing role of cleanroom technology in regulatory frameworks has been understood by industries such as pharmaceutical and biotechnology, hardware, medical device manufacturing, electronics, semiconductor manufacturing, food, and plastics. They consider the software a key enabler for them to demonstrate their compliance with the changing rules, especially on new product approvals. The introduction of innovative techniques to manage pollution has been instrumental in transforming the nature of the demand for clean-room technology.

Click here to get a free sample report: 
The cleanroom technology market is driven by growing regulatory concerns about the packaging, manufacturing, and distribution of better-quality goods and the protection of people associated with such work. Moreover, the increasing developments in cleanroom technology are another factor that is likely to have a positive impact on the growth in demand for cleanroom doors in the coming years. The growing compliance of emerging economies with foreign regulations in the healthcare industry creates tremendous growth opportunities for players in the market for cleanroom technology. Key players are likely to focus on product innovations and expansion through mergers to retain their positions in developed markets.


The key drivers that propelled the market demand in the forecast period are rising cleanroom technology adoption and technological innovation in cleanroom technology. Cleanroom refers to a room where air-generated particulate matter accumulation is managed. A cleanroom is designed to reduce the output, absorption, and retention of particles inside the room by maintaining the right conditions for temperature, pressure, and humidity. There is a rapid increase in developments in science and technology, regulatory enforcement and competition in the cleanroom consumables market, the need for industry-specific cleanrooms, and a regulated environment. These market-driven forces have accelerated the production and growth of modular cleanroom systems over the last few years to meet specific and complicated research requirements.

Global Cleanroom Technology Market is segmented by end-user into Pharmaceutical, Biotechnology, Medical device, Others. The pharmaceutical industry segment is projected to rise to the highest CAGR during the forecast period due to the introduction of favourable rules and regulations on the use of cleanroom technology in the healthcare sector. Compared to the precise year, demand for cleanroom technology has increased with the increased use of cleanroom technology in the pharmaceutical industry to prevent drug contamination and sterile pharmaceutical formulations, along with the implementation of enhanced technologically advanced cleanroom technology.

Some of the key players operating in Global Cleanroom Technology are:
  • Simplex Isolation Systems
  • AES Clean Technology
  • DuPont
  • Clean Air Products
  • Clean Room Depot Inc.
  • Exyte AG (A subsidiary of M+W Group)
  • Integrated Cleanroom Technologies Private Limited
  • Hemair
  • AIRTECH JAPAN Ltd.
  • Lennox International IncNicos Group Inc.
  • Galvani S.R.L
  • Ardmac
  • Azbil Corporation
  • Novum
  • Reinraumtechnik
  • Helapet Ltd.
  • KCWW
  • Camfil
  • Labconco
  • Taikisha Ltd
  • Terra Universal. Inc.
  • Lindner Group.

Read more..

Global Auto Injector Market

Press Release - The autoinjectors market is projected to be worth around USD 153.1 Billion by 2027

Rise in prevalence of chronic diseases and the corresponding need to medicate frequently, have led to an increase in demand for safe, self-administrable dosing options. Autoinjectors are considered among the leading product classes in this category.

Auto injectors are an effective mode of administration for intramuscular drugs. User friendly attributes of auto injectors reduce the burden of carrying conventional needles and syringes. However, limited awareness regarding proper use of auto injectors and high price of branded products are some of the important factors curbing the adoption of auto injector devices in emergency applications. 

Increasing innovations in materials and device functions of auto-injectors are driving the expansion of the auto injector market. Bayer HealthCare launched Betaconnect- an electronic auto injector for the treatment of relapsing-remitting multiple sclerosis (RRMS). This auto injector offers complete drug dosage for improved compliance and potentially reduce the overall cost. The SHL Group offers a variety of auto injectors that can accommodate changes in injections, such as larger volumes, high viscosity and others. The auto-injector manufacturers are focusing on improving the functionality of auto-injectors to improve disease management and treatment.

Click here to get a free sample report: 
Fierce competition in the auto injectors market due to the patient protection act has created an oligopolistic market environment. As a result, brands, such as EpiPen auto-injector, BD Physioject disposable auto injector, etc., have maintained their ranks in the market. However, recent patient expiration and increasing pressure from government bodies will led to reduction in auto injector prices and thus, reduce the profitability for branded manufacturers. Generic auto injectors are expected to present high growth opportunities for investors due to growing support from private insurance providers. Insurance services providers are dropping coverage on highly priced auto injectors and covering newly launched half priced generics. Overall revenue from pre-filled syringes is expected to grow during the forecast period due to rising need for targeted and sustained drug delivery. New entrants must comprehensively study the Auto Injectors market to penetrate and sustain in the price sensitive market. The study of the market scenario will provide insights about the business opportunities.


The global auto injector market by product type, therapy type, indication, route of distribution, end user, & regions. In terms of revenues, pre-filled auto injectors will hold substantial market share over the forecast period. On the contrary, the Fillable auto-injectors segment will exhibit limited investment opportunities, in terms of revenue, through 2027.

Some of the key companies operating in the auto injectors market, such as:
  • Sanofi
  • Pfizer Inc.
  • Becton
  • Dickinson and Company
  • Mylan N.V.
  • Novartis AG
  • Janssen Global Services LLC
  • Antares Pharma
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Company.

Read more..

Join SPER Market Research Team!

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Secure Payments
SPER Payment Options
Connect with us